1 Existing treatment for ovarian cancer: recent advances and description of unmet needs S Banerjee
2 Discovery of novel targets J Farley
3 Anti-angiogenesis - update on its application in ovarian cancer J Hasan
4 Targeting the PI3K/AKT pathway E Stronach
5 Inhibition of the SRC oncogene; potential in ovarian cancer LY Han
6 Tumour specific synthetic lethality; targeting BRCA gene dysfunction TA Yap
7 Inhibition of cytokines and chemokines in ovarian cancer J Coward
8 Potential for inhibition of membrane receptors (EGF, IGF, c-MET, and others) LP Martin
9 An epigenetic approach to ovarian cancer R Brown
10 Immunotherapy; update on its application in ovarian cancer S Ghaem-Maghami
11 Ovarian cancer progenitor/stem cells; therapeutic potential S Murphy
12 Potential for a-folate receptor targeted treatment for ovarian cancer CHM Ng
13 New insights into tubulin binders J Brenton
Discusses the progress in linking the biology of ovarian cancer with novel targets and innovative therapies entering clinical trials.
Provides an up-to-date perspective on successful therapeutic developments as a partnership between laboratory-based and clinical-based research scientists.
Identifies those areas of translational research which we believe have shown the most promise, or are likely to do so, in the treatment of ovarian cancer.